Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical Importance of the lncRNA NEAT1 in Cancer Patients Treated with Immune Checkpoint Inhibitors
Joseph Toker, J. Bryan Iorgulescu, Alexander Ling, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 12, pp. 2226-2238
Open Access | Times Cited: 23

Showing 23 citing articles:

Exploring the role of lncrna neat1 knockdown in regulating apoptosis across multiple cancer types: A review
Md Sadique Hussain, Gaurav Gupta, Muhammad Afzal, et al.
Pathology - Research and Practice (2023) Vol. 252, pp. 154908-154908
Closed Access | Times Cited: 54
Targeting the PD-1/PD-L1 Signaling Pathway for Cancer Therapy: Focus on Biomarkers
Αreti Strati, Christos Adamopoulos, Ioannis Kotsantis, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1235-1235
Open Access | Times Cited: 2
Anti-PD-1/PD-L1 therapy for colorectal cancer: Clinical implications and future considerations
Xiang Chen, Lingjuan Chen, Xiaofei Peng, et al.
Translational Oncology (2023) Vol. 40, pp. 101851-101851
Open Access | Times Cited: 24
Long Non-Coding RNAs in Colorectal Cancer: Navigating the Intersections of Immunity, Intercellular Communication, and Therapeutic Potential
Nikolay K. Shakhpazyan, Л.М. Михалева, A.L. Bedzhanyan, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2411-2411
Open Access | Times Cited: 19
Lessons learned from phase 3 trials of immunotherapy for glioblastoma: Time for longitudinal sampling?
Ethan Chen, Alexander Ling, David A. Reardon, et al.
Neuro-Oncology (2023) Vol. 26, Iss. 2, pp. 211-225
Open Access | Times Cited: 16
Isoform balance of the long noncoding RNA NEAT1 is regulated by the RNA-binding protein QKI, governs the glioma transcriptome, and impacts cell migration
Paul M. Zakutansky, Li Ku, Guannan Zhang, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 8, pp. 107595-107595
Open Access | Times Cited: 6
Long Non-Coding RNAs in Malignant Human Brain Tumors: Driving Forces Behind Progression and Therapy
Dakun Pei, Dandan Zhang, Yan Guo, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 694-694
Open Access
Targeting ferroptosis: a promising approach for treating lung carcinoma
Ziyang Wu, Tao Zhang, Wei Zhong, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Novel Biological Strategies for Melanoma Therapy: A Focus on lncRNAs and Their Targeting
Francesca Maria Orlandella, Rosaria Arcone, Neila Luciano, et al.
Cancers (2025) Vol. 17, Iss. 8, pp. 1273-1273
Open Access
The landscape of immune checkpoint-related long non-coding RNAs core regulatory circuitry reveals implications for immunoregulation and immunotherapy responses
Changfan Qu, Hao Cui, Xiao Song, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 3
Deciphering the code: the pivotal role of lncRNAs in advancing TNBC therapy
Weiping Chen, Zhiyong Pan, Zhengfu Feng, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Profiling hypoxia signaling reveals a lncRNA signature contributing to immunosuppression in high-grade glioma
Xinqiao Li, Jingcheng Xu, Xue Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Multimodal data fusion AI model uncovers tumor microenvironment immunotyping heterogeneity and enhanced risk stratification of breast cancer
Yunfang Yu, Gengyi Cai, Ruichong Lin, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access | Times Cited: 2
lncRNAs-EZH2 interaction as promising therapeutic target in cutaneous melanoma
Michał Woźniak, Małgorzata Czyż
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 6
Systematic transcriptomic analysis of childhood medulloblastoma identifies N6-methyladenosine-dependent lncRNA signatures associated with molecular subtype, immune cell infiltration, and prognosis
Kandarp Joshi, Menglang Yuan, Keisuke Katsushima, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Revision of Functionally Relevant and Widely Expressed Long Non-Coding RNAs
Daria Konina, Mikhail Skoblov
Molecular Biology (2024) Vol. 58, Iss. 3, pp. 557-569
Closed Access | Times Cited: 1
Molecular Mechanisms of Tumorgenesis and Metastasis of Long Non-coding RNA (lncRNA) NEAT1 in Human Solid Tumors; An Update
Mohammad Y. Alshahrani, Raed Obaid Saleh, Ahmed Hjazi, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 2, pp. 593-607
Closed Access | Times Cited: 1
Research progress on function and mechanism of long non-coding RNA in glioma
Feipeng Tai, Xueming Zhao
Cellular and Molecular Biology (2024) Vol. 70, Iss. 5, pp. 233-237
Open Access | Times Cited: 1
Neoadjuvant anti-PD1 immunotherapy for surgically accessible recurrent glioblastoma: clinical and molecular outcomes of a stage 2 single-arm expansion cohort
J. Ricardo McFaline‐Figueroa, Lu Sun, Gehad Youssef, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Long non‑coding RNAs, lipid metabolism and cancer (Review)
Zhendong Zhang, Xin-Rui Hou, Xiao−Lan Cao, et al.
Experimental and Therapeutic Medicine (2023) Vol. 26, Iss. 4
Open Access | Times Cited: 2
An extensive overview of the role of lncRNAs generated from immune cells in the etiology of cancer
Hong Luo, Hailiang Jing, Wei Chen
International Immunopharmacology (2024) Vol. 133, pp. 112063-112063
Closed Access
Systematic transcriptomic analysis of childhood medulloblastoma identifies N6- methyladenosine-dependent lncRNA signatures associated with molecular subtype, immune cell infiltration, and prognosis
Kandarp Joshi, Menglang Yuan, Keisuke Katsushima, et al.
Research Square (Research Square) (2024)
Open Access
Lnc NEAT1 facilitates the progression of melanoma by targeting the miR-152-3p/CDK6 axis: An observational study
Ning Ning, Zeyu Tian, Hao Feng, et al.
Medicine (2024) Vol. 103, Iss. 44, pp. e40379-e40379
Open Access
The role of lncRNA NEAT1 in acute graft-versus-host disease: Regulation of macrophage polarization and inflammatory cytokine secretion via JNK/NLRP3 pathway
Zhen‐Li Huang, Li Wang, Jian Li, et al.
International Immunopharmacology (2024) Vol. 146, pp. 113857-113857
Closed Access
Page 1

Scroll to top